Apeiron Biologics

Two biotech companies, APEIRON and Evotec, have received the first milestone payment from Sanofi as part of the three-party immune-oncology alliance that was signed in 2015. Read more


Apeiron Biologics, a biotech company focused on immunologic and biologic therapies against cancer, and Rentschler Biotechnologie, a full service biopharmaceutical contract manufacturer, have jointly announced a partnership agreement to manufacture... Read more